Human p53 tumor suppressor gene (TP53) and schizophrenia: Case-control and family studies

Neuroscience Letters

Volumn 388, Issue 3, 2005, Pages 173-178

  Ni, Xingqun ^a   Trakalo, Joseph ^a   Valente, Jose ^b   Azevedo, Maria H ^b   Pato, Michelle T ^c   Pato, Carlos N ^c   Kennedy, James L ^a,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Case control study; Genetics; Haplotype analysis; p53 tumor suppressor gene; Schizophrenia; Transmission disequilibrium test

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; TUMOR SUPPRESSOR GENE;

BRAIN CHEMISTRY; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; ONTARIO; POLYMORPHISM, GENETIC; PORTUGAL; SCHIZOPHRENIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 23944434184     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.06.050     Document Type: Article

References (58)

1. R.S. Aloyz, S.X. Bamji, C.D. Pozniak, J.G. Toma, J. Atwal, D.R. Kaplan, and F.D. Miller p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors J. Cell Biol. 143 1998 1691 1703
2. N.C. Andreasen The role of the thalamus in schizophrenia Can. J. Psychiatry 42 1997 27 33
3. J.F. Armstrong, M.H. Kaufman, D.J. Harrison, and A.R. Clarke High-frequency developmental abnormalities in p53-deficient mice Curr. Biol. 5 1995 931 936
4. S.E. Arnold, and J.Q. Trojanowski Recent advances in defining the neuropathology of schizophrenia Acta Neuropathol. (Berl.) 92 1996 217 231
5. F.M. Benes, E.W. Kwok, S.L. Vincent, and M.S. Todtenkopf A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives Biol. Psychiatry 44 1998 88 97
6. F.M. Benes, J. McSparren, E.D. Bird, J.P. SanGiovanni, and S.L. Vincent Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients Arch. Gen. Psychiatry 48 1991 996 1001
7. F.M. Benes, S.L. Vincent, and M. Todtenkopf The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects Biol. Psychiatry 50 2001 395 406
8. F.M. Benes, J. Walsh, S. Bhattacharyya, A. Sheth, and S. Berretta DNA fragmentation decreased in schizophrenia but not bipolar disorder Arch. Gen. Psychiatry 60 2003 359 364
9. K. Berns, E.M. Hijmans, J. Mullenders, T.R. Brummelkamp, A. Velds, M. Heimerikx, R.M. Kerkhoven, M. Madiredjo, W. Nijkamp, B. Weigelt, R. Agami, W. Ge, G. Cavet, P.S. Linsley, R.L. Beijersbergen, and R. Bernards A large-scale RNAi screen in human cells identifies new components of the p53 pathway Nature 428 2004 431 437
10. J.M. Bland, and D.G. Altman Statistics notes. The odds ratio BMJ 320 2000 1468
11. Brain tissue loss in schizophrenia Harv. Ment. Health Lett. 18 2002 7
12. S.V. Catts, P.B. Ward, A. Lloyd, X.F. Huang, G. Dixon, L. Chahl, C. Harper, and D. Wakefield Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia Aust. N. Z. J. Psychiatry 31 1997 17 26
13. V.S. Catts, and S.V. Catts Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr. Res. 41 2000 405 415
14. H.J. Chiu, Y.C. Wang, J.Y. Chen, C.J. Hong, and S.J. Tsai Association study of the p53-gene Pro72Arg polymorphism in schizophrenia Psychiatry Res. 105 2001 279 283
15. D. Daily, A. Barzilai, D. Offen, A. Kamsler, E. Melamed, and I. Ziv The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53 Cell Mol. Neurobiol. 19 1999 261 276
16. F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes Genet. Epidemiol. 25 2003 115 121
17. P. Dumont, J.I. Leu, A.C. Della Pietra 3rd, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
18. I. Ferrer, E. Soriano, J.A. del Rio, S. Alcantara, and C. Auladell Cell death and removal in the cerebral cortex during development Prog. Neurobiol. 39 1992 1 43
19. R. Freedman, S. Leonard, A. Olincy, C.A. Kaufmann, D. Malaspina, C.R. Cloninger, D. Svrakic, S.V. Faraone, and M.T. Tsuang Evidence for the multigenic inheritance of schizophrenia Am. J. Med. Genet. 105 2001 794 800
20. P.A. Gaspar, M.H. Hutz, F.M. Salzano, and T.A. Weimer TP53 polymorphisms and haplotypes in South Amerindians and neo-Brazilians Ann. Hum. Biol. 28 2001 184 194
21. S.M. Gibbs Regulation of neuronal proliferation and differentiation by nitric oxide Mol. Neurobiol. 27 2003 107-20
22. C.P. Gilman, and M.P. Mattson Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromol. Med. 2 2002 197 214
23. T.A. Greenwood, and J.R. Kelsoe Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene Genomics 82 2003 511 520
24. I. Harvey, M.A. Ron, G. Du Boulay, D. Wicks, S.W. Lewis, and R.M. Murray Reduction of cortical volume in schizophrenia on magnetic resonance imaging Psychol. Med. 23 1993 591 604
25. C.A. Heid, J. Stevens, K.J. Livak, and P.M. Williams Real time quantitative PCR Genome Res. 6 1996 986 994
26. E.S. Hickman, M.C. Moroni, and K. Helin The role of p53 and pRB in apoptosis and cancer Curr. Opin. Genet. Dev. 12 2002 60 66
27. L.J. Hofseth, S.P. Hussain, and C.C. Harris p53: 25 years after its discovery Trends Pharmacol. Sci. 25 2004 177-81
28. H. Jacquet, G. Raux, F. Thibaut, B. Hecketsweiler, E. Houy, C. Demilly, S. Haouzir, G. Allio, G. Fouldrin, V. Drouin, J. Bou, M. Petit, D. Campion, and T. Frebourg PRODH mutations and hyperprolinemia in a subset of schizophrenic patients Hum. Mol. Genet. 11 2002 2243 2249
29. S. Johnson Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med. Hypotheses 56 2001 641 645
30. J.L. Kennedy, L.A. Farrer, N.C. Andreasen, R. Mayeux, and P. St George-Hyslop The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302 2003 822 826
31. M. Knapp A note on power approximations for the transmission/ disequilibrium test Am. J. Hum. Genet. 64 1999 1177 1185
32. E.A. Komarova, M.V. Chernov, R. Franks, K. Wang, G. Armin, C.R. Zelnick, D.M. Chin, S.S. Bacus, G.R. Stark, and A.V. Gudkov Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo EMBO J. 16 1997 1391 1400
33. F.A. Kondrashov, and E.V. Koonin Evolution of alternative splicing: deletions, insertions and origin of functional parts of proteins from intron sequences Trends Genet. 19 2003 115 119
34. D.K. Lahiri, and J.I. Nurnberger Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res. 19 1991 5444
35. S.M. Lawrie, and S.S. Abukmeil Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies Br. J. Psychiatry 172 1998 110 120
36. H. Le Hir, A. Nott, and M.J. Moore How introns influence and enhance eukaryotic gene expression Trends Biochem. Sci. 28 2003 215 220
37. Y. Li, C.L. Schlamp, G.L. Poulsen, M.W. Jackson, A.E. Griep, and R.W. Nickells p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-d-aspartate Mol. Vis. 8 2002 341 350
38. E.A. Lovejoy, A.C. Scott, C.E. Fiskerstrand, V.J. Bubb, and J.P. Quinn The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit Eur. J. Neurosci. 17 2003 417 420
39. F.D. Miller, C.D. Pozniak, and G.S. Walsh Neuronal life and death: an essential role for the p53 family Cell Death Differ. 7 2000 880 888
40. T. Morris, B. Robertson, and M. Gallagher Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system J. Clin. Microbiol. 34 1996 2933 2936
41. R.S. Morrison, Y. Kinoshita, M.D. Johnson, W. Guo, and G.A. Garden p53-dependent cell death signaling in neurons Neurochem. Res. 28 2003 15 27
42. B. Pakkenberg Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics Arch. Gen. Psychiatry 47 1990 1023 1028
43. S. Papiol, B. Arias, N. Barrantes-Vidal, M. Guitart, P. Salgado, R. Catalan, and L. Fananas Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits Neurosci. Lett. 363 2004 78 80
44. J.K. Park, H.J. Lee, J.W. Kim, Y.H. Park, S.S. Lee, H.I. Chang, J.Y. Song, D.J. Yoon, G.H. Bahn, Y.H. Shin, Y.J. Kim, S.A. Kim, B.K. Choe, C.J. Kim, and J.H. Chung Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients Schizophr. Res. 67 2004 71 74
45. K. Polyak, Y. Xia, J.L. Zweier, K.W. Kinzler, and B. Vogelstein A model for p53-induced apoptosis Nature 389 1997 300 305
46. S. Porat, A. Premkumar, and R. Simantov Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53 Dev. Neurosci. 23 2001 432 440
47. V.P. Sah, L.D. Attardi, G.J. Mulligan, B.O. Williams, R.T. Bronson, and T. Jacks A subset of p53-deficient embryos exhibit exencephaly Nat. Genet. 10 1995 175 180
48. S. Sakhi, A. Bruce, N. Sun, G. Tocco, M. Baudry, and S.S. Schreiber p53 induction is associated with neuronal damage in the central nervous system Proc. Natl. Acad. Sci. U.S.A. 91 1994 7525 7529
49. P.M. Thompson, C. Vidal, J.N. Giedd, P. Gochman, J. Blumenthal, R. Nicolson, A.W. Toga, and J.L. Rapoport Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia Proc. Natl. Acad. Sci. U.S.A. 98 2001 11650 11655
50. N.A. Uranova, V.M. Vostrikov, D.D. Orlovskaya, and V.I. Rachmanova Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium Schizophr. Res. 67 2004 269 275
51. M. van Lookeren Campagne, and R. Gill Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax J. Comp. Neurol. 397 1998 181 198
52. J.L. Waddington, A. Lane, P.J. Scully, C. Larkin, and E. O'Callaghan Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease? Psychiatr. Clin. North Am. 21 1998 123 149
53. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch. Gen. Psychiatry 44 1987 660 669
54. A.H. Wong, F. Macciardi, T. Klempan, W. Kawczynski, C.L. Barr, S. Lakatoo, M. Wong, C. Buckle, J. Trakalo, E. Boffa, J. Oak, M.H. Azevedo, A. Dourado, I. Coelho, A. Macedo, A. Vicente, J. Valente, C.P. Ferreira, M.T. Pato, C.N. Pato, J.L. Kennedy, and H.H. Van Tol Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene Mol. Psychiatry 8 2003 156 166
55. X. Yang, R. Klein, X. Tian, H.T. Cheng, R. Kopan, and J. Shen Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway Dev. Biol. 269 2004 81 94
56. Y. Yang, Z. Xiao, W. Chen, H. Sang, Y. Guan, Y. Peng, D. Zhang, Z. Gu, M. Qian, G. He, W. Qin, D. Li, N. Gu, and L. He Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population Neurosci. Lett. 369 2004 126 131
57. H.W. Yung, A.K. Bal-Price, G.C. Brown, and A.M. Tolkovsky Nitric oxide-induced cell death of cerebrocortical murine astrocytes is mediated through p53- and Bax-dependent pathways J. Neurochem. 89 2004 812 821
58. R.B. Zipursky, K.O. Lim, E.V. Sullivan, B.W. Brown, and A. Pfefferbaum Widespread cerebral gray matter volume deficits in schizophrenia Arch. Gen. Psychiatry 49 1992 195 205